Loading clinical trials...
Loading clinical trials...
Randomized, Controlled, Double-blind, Multi-center Trial to Evaluate the Efficacy and Safety of an Esflurbiprofen Topical System (EFTS) vs. Placebo in the Local Symptomatic and Short-term Treatment of Pain in Ankle Sprains.
This study is a multi-center, double-blind, randomized controlled trial to evaluate the efficacy and safety of EFTS vs. placebo in patients with ankle sprains. The primary objective of this study is to demonstrate that the EFTS is superior in pain reduction compared to a matching placebo in patients with ankle sprains. The secondary objective is to evaluate tolerability, local tolerability, and adhesion of EFTS vs. placebo.
Age
18 - 64 years
Sex
ALL
Healthy Volunteers
No
Medical Practice Ebert
Siemensstr, Bonn, Germany
Medical Practice Prof. Predel
Siemensstr, Bonn, Germany
Medical Practice Schaale-Maas
Siemensstr, Bonn, Germany
Medical Practice Pabst
Sportschule Puch, Fürstenfeldbruck, Germany
Medical Practice Gastl
Römerstraße, Gilching, Germany
Start Date
March 31, 2025
Primary Completion Date
October 18, 2025
Completion Date
October 30, 2025
Last Updated
November 26, 2025
69
ACTUAL participants
Esflurbiprofen Topical System (EFTS)
DRUG
Placebo Patch
DRUG
Lead Sponsor
Teikoku Seiyaku Co., Ltd.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06905418